An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.
Type 1 diabetes mellitus (T1DM) is an autoimmune disease where the immune system attacks insulin-beta cells in the pancreas, leading to high blood sugar resulting from insulin deficiency. Unlike type ...
Approximately 1 in 56 men and 1 in 60 women will be diagnosed with pancreatic cancer at some point in their lives, and Pennsylvania has slightly higher rates ...